Skip to main content
Finemedix Co., Ltd. logo

Finemedix Co., Ltd. — Investor Relations & Filings

Ticker · 387570 ISIN · KR7387570005 KO Manufacturing
Open in API
Filings indexed 56 across all filing types
Latest filing 2025-01-02 Major Shareholding Noti…
Country KR South Korea
Listing KO 387570

About Finemedix Co., Ltd.

https://finemedix.com/en/

Finemedix Co., Ltd. is a medical device company that develops and manufactures surgical equipment, specializing in instruments for endoscopic procedures. The company's product portfolio supports diagnostic and therapeutic applications, including Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) and Fine Needle Biopsy (EUS-FNB) devices, hemostatic clips for bleeding control, and tools for Endoscopic Submucosal Dissection (ESD) and polypectomy. Finemedix operates on a prosumer model, directly involving medical personnel in the product development process to create devices tailored to clinical needs.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (DART system) used when an entity acquires a significant stake (typically 5% or more) in a listed company. This specific document details the Korea SMEs and Startups Agency's shareholding in 'FineMedics' following its KOSDAQ listing. This falls under the category of Major Shareholding Notification.
2025-01-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the shareholding status of a specific individual (Jeon Seong-woo, CEO of FineMedic) following the company's KOSDAQ listing. This is a standard regulatory filing in South Korea for insider share ownership, which falls under the 'Director's Dealing' category as it reports personal shareholdings and changes by a company executive.
2024-12-31 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and Korea Exchange. It details the share ownership and changes in holdings for a specific executive (Kim Sung-chul) of FineMedix. This type of filing is a standard regulatory disclosure for insider holdings, which corresponds to the 'Director's Dealing' category.
2024-12-31 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (DART). This type of filing is specifically used to report insider shareholdings and transactions by directors or major shareholders. In the provided taxonomy, 'Director's Dealing' (DIRS) is the correct category for reports detailing personal share transactions or ownership status by company directors and executives.
2024-12-31 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document type is used to notify the market when a person or entity acquires a significant stake (typically 5% or more) in a company. In the provided classification schema, this corresponds to a 'Major Shareholding Notification'.
2024-12-31 Korean
증권발행실적보고서
Share Issue/Capital Change Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed by FineMedix Co., Ltd. to the Financial Supervisory Service (FSS) in South Korea. This document details the final results of a public offering, including subscription status, allocation results, and the use of proceeds. In the context of Korean regulatory filings (DART), this is a standard report filed after the completion of a capital raising event (IPO/Public Offering). Among the provided categories, 'SHA' (Share Issue/Capital Change) is the most appropriate classification as it covers announcements regarding new share issues and capital changes resulting from such offerings.
2024-12-19 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.